Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

LABORATORY CORPORATION OF AMERICA

NPI: 1043891336 · SOUTH BEND, IN 46628 · Clinical Medical Laboratory · NPI assigned 04/19/2021

Billing Flags · Automated signals — not evidence of fraud
Entity Proliferation

Authorized official WILLIAMS, KIMBERLY controls 20+ related entities in our dataset. Read more

$2.46M
Total Medicaid Paid
106,776
Total Claims
85,668
Beneficiaries
54
Codes Billed
2021-10
First Month
2024-12
Last Month

Provider Details

Authorized OfficialWILLIAMS, KIMBERLY (VICE PRESIDENT)
NPI Enumeration Date04/19/2021

Related Entities

Other providers sharing the same authorized official: WILLIAMS, KIMBERLY

ProviderCityStateTotal Paid
LABORATORY CORPORATION OF AMERICA HOLDINGS BURLINGTON NC $1.44B
LABORATORY CORPORATION OF AMERICA HOLDINGS RARITAN NJ $717.47M
LABORATORY CORPORATION OF AMERICA HOLDINGS DUBLIN OH $617.02M
LABORATORY CORPORATION OF AMERICA HOLDINGS BIRMINGHAM AL $289.12M
LABORATORY CORPORATION OF AMERICA PHOENIX AZ $265.90M
LABORATORY CORPORATION OF AMERICA HOLDINGS BURLINGTON NC $264.26M
LABORATORY CORPORATION OF AMERICA HOLDINGS CHARLESTON WV $220.04M
LABORATORY CORPORATION OF AMERICA SEATTLE WA $186.69M
LABORATORY CORPORATION OF AMERICA TAMPA FL $171.13M
LABORATORY CORPORATION OF AMERICA SAN DIEGO CA $147.14M
LABORATORY CORPORATION OF AMERICA HOUSTON TX $103.81M
LABORATORY CORPORATION OF AMERICA ENGLEWOOD CO $77.80M
LABORATORY CORPORATION OF AMERICA DALLAS TX $77.42M
LABORATORY CORPORATION OF AMERICA BURLINGTON NC $59.75M
MEDTOX LABORATORIES, INC SAINT PAUL MN $47.72M
LABORATORY CORPORATION OF AMERICA HOLDINGS BURLINGTON NC $15.65M
LABORATORY CORPORATION OF AMERICA SAN ANTONIO TX $11.67M
TRI-CITIES LABORATORY, LLC KENNEWICK WA $8.69M
LABORATORY CORPORATION OF AMERICA HOLDINGS MONROE LA $3.39M
LABORATORY CORPORATION OF AMERICA ITASCA IL $3.37M

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2021 20,625 $556K
2022 56,907 $1.73M
2023 15,739 $93K
2024 13,505 $85K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 36,091 27,517 $1.79M
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 27,115 20,298 $410K
87086 Culture, bacterial; quantitative colony count, urine 9,846 8,700 $51K
87088 4,136 3,699 $21K
87186 2,875 2,594 $17K
82728 2,633 2,328 $16K
80053 Comprehensive metabolic panel 3,296 2,549 $16K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms 242 210 $12K
87077 2,446 2,177 $12K
87150 421 406 $11K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 468 404 $11K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 468 404 $11K
84443 Thyroid stimulating hormone (TSH) 1,650 1,358 $10K
83550 2,291 2,044 $9K
83540 2,300 2,052 $7K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 431 377 $7K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 392 172 $6K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 125 113 $5K
87081 974 899 $5K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 145 125 $5K
81001 1,817 1,748 $4K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 237 193 $4K
82607 579 507 $3K
84439 800 692 $3K
82378 300 258 $3K
83615 942 801 $2K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 628 474 $2K
80177 201 164 $1K
36415 Collection of venous blood by venipuncture 531 376 $1K
82784 194 136 $1K
82746 179 160 $1K
86334 142 122 $883.10
85379 163 145 $800.04
87070 125 120 $759.58
80061 Lipid panel 121 94 $664.73
81003 339 337 $646.61
80050 General health panel 17 13 $520.40
84165 183 160 $453.63
84702 52 26 $322.75
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 60 49 $277.58
87205 71 67 $219.80
85027 68 41 $210.31
83036 Hemoglobin; glycosylated (A1C) 61 48 $208.51
84144 27 14 $203.36
84155 201 176 $138.02
83735 45 25 $132.65
80048 Basic metabolic panel (calcium, ionized) 90 78 $126.67
85046 44 38 $118.17
85045 53 48 $109.01
82570 13 13 $59.09
85610 20 13 $49.77
G0307 Complete (cbc), automated (hgb, hct, rbc, wbc; without platelet count) 80 61 $45.29
85652 35 32 $44.12
84156 13 13 $30.33